Dozens of neo-Nazis are fleeing Telegram and moving to a relatively unknown secret chat app that has received funding from Twitter founder Jack Dorsey. While ISD stopped short of naming SimpleX in its ...
ROOTSTOWN, Ohio--(BUSINESS WIRE)--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, ...
Dozens of neo-Nazis are fleeing Telegram and moving to a relatively unknown secret chat app that has received funding from Twitter founder Jack Dorsey. While ISD stopped short of naming SimpleX in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback